Drugs / Cultured Thymus Tissue for Implantation (CTTI)
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00579527 | Dec 2005 → Dec 2011 | DiGeorge syndrome | Sumitomo Pharma Switzerland GmbH | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00576407 | Oct 1991 → Apr 2009 | DiGeorge syndrome | Sumitomo Pharma Switzerland GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cultured Thymus Tissue for Implantation (CTTI) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00576407 ↗ |
| Route | Other | “thymus slices were implanted into the recipient's quadriceps” NCT00576407 ↗ |